Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?

Literature DB >> 23332395

Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?

Ohad Benjamini¹, Preetesh Jain, Ellen Schlette, Jade S Sciffman, Zeev Estrov, Michael Keating.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23332395 PMCID： PMC4167026 DOI： 10.1016/j.clml.2012.12.007

Source DB: PubMed Journal: Clin Lymphoma Myeloma Leuk ISSN： 2152-2669

× No keyword cloud information.

18 in total

1. Leukemic meningitis in B-cell chronoc lymphocytic leukemia: resolution following intrathecal methotrexate.

Authors: A M Marmont
Journal: Blood Date: 2000-07-15 Impact factor: 22.113

2. Primary malignant meningeal melanomatosis: a clinical, radiological and pathologic case study.

Authors: Manuel Arias; Miguel Alberte-Woodward; Susana Arias; Dolores Dapena; Angel Prieto; José Manuel Suárez-Peñaranda
Journal: Acta Neurol Belg Date: 2011-09 Impact factor: 2.396

3. Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.

Authors: Jose-Manuel Calvo-Villas; Jose Antonio Fernández; Ignacio de la Fuente; Ana Cristina Godoy; M Carmen Mateos; Concepcion Poderós
Journal: Br J Haematol Date: 2010-05-13 Impact factor: 6.998

4. Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy.

Authors: Georg Russwurm; Michael Heinsch; Robert Radkowski; Rainer Erlemann; Carlo Aul; Sabine Haase; Aristoteles Giagounidis
Journal: Blood Date: 2010-10-07 Impact factor: 22.113

5. Clinical significance of monoclonal B cells in cerebrospinal fluid.

Authors: Grzegorz S Nowakowski; Timothy G Call; William G Morice; Paul J Kurtin; Rachel J Cook; Clive S Zent
Journal: Cytometry B Clin Cytom Date: 2005-01 Impact factor: 3.058

6. Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment.

Authors: M C J Hanse; M B Van't Veer; K van Lom; M J van den Bent
Journal: J Neurol Date: 2008-04-30 Impact factor: 4.849

7. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors: Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal: J Neurooncol Date: 2011-07-17 Impact factor: 4.130

Review 8. Spectrum of neurologic complications in chronic lymphocytic leukemia.

Authors: Rodrigo Lopes da Silva
Journal: Clin Lymphoma Myeloma Leuk Date: 2011-12-21

9. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.

Authors: James L Rubenstein; Jane Fridlyand; Lauren Abrey; Arthur Shen; Jon Karch; Endi Wang; Samar Issa; Lloyd Damon; Michael Prados; Michael McDermott; Joan O'Brien; Chris Haqq; Marc Shuman
Journal: J Clin Oncol Date: 2007-02-20 Impact factor: 44.544

10. Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

Authors: Stefan Knop; Ulrich Herrlinger; Ulrike Ernemann; Lothar Kanz; Holger Hebart
Journal: Leuk Lymphoma Date: 2005-11

7 in total

7. Chronic Lymphocytic Leukemia Involvement of Central Nervous System: Clinical Diversity, Diagnostic Algorithm and Therapeutic Challenges.

Authors: Biljana Mihaljevic; Mihailo Smiljanic; Darko Antic; Nada Kraguljac Kurtovic; Milena Todorovic Balint
Journal: Ann Indian Acad Neurol Date: 2018 Jan-Mar Impact factor: 1.383

7 in total

Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?

1. Leukemic meningitis in B-cell chronoc lymphocytic leukemia: resolution following intrathecal methotrexate.

2. Primary malignant meningeal melanomatosis: a clinical, radiological and pathologic case study.

3. Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.

4. Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy.

5. Clinical significance of monoclonal B cells in cerebrospinal fluid.

6. Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment.

7. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Review 8. Spectrum of neurologic complications in chronic lymphocytic leukemia.

9. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.

10. Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

1. Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Review 2. Central nervous system niche involvement in the leukemia.

3. Brain biopsy in the diagnosis of leptomeningeal involvement in stage I chronic lymphocytic leukemia.

4. Treatment Sequencing in a Chronic Lymphocytic Leukemia Patient with Central Nervous System Involvement.

Review 5. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.

6. Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.

7. Chronic Lymphocytic Leukemia Involvement of Central Nervous System: Clinical Diversity, Diagnostic Algorithm and Therapeutic Challenges.